Angeliki Ntineri

Angeliki Ntineri

Auto-generated profile, based on publicly available information

Angeliki Ntineri

Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Journal Of Hypertension
Verified
Journal Article
Closed access
Anastasios KolliasAnastasios Kollias
Anastasios Kollias
MDMaria Dafni
Maria Dafni
EPEmmanouil Poulidakis
Emmanouil Poulidakis
ANAngeliki Ntineri
Angeliki Ntineri
GSGeorge Stergiou
George Stergiou
In children, out-of-office blood pressure (BP) assessment (especially ambulatory monitoring) is regarded as indispensable for accurate hypertension diagnosis. This article reviewed the evidence on the association between out-of-office BP measurements and preclinical organ damage indices in children. A systematic review and meta-analysis of 93 relevant articles (1974-2012) was performed. Analysis of 10 studies (n = 480, pooled age 14.4 years, with hypertension 33%, renal disease 27%, type 1 diabetes 10%) revealed a significant association between systolic ambulatory BP and left ventricular mass index (LVMI), with pooled correlation coefficient r = 0.40 [95% confidence interval (CI) 0.30-0.50]. Eleven studies reported data on LVMI differences between normotensive (n = 428) and hypertensive children (n = 432), with higher values in the latter group by 6.53 g/m(2.7) (95% CI 4.73-8.33). A moderate association was found between systolic ambulatory BP and carotid intima-media thickness (three studies, n = 231, age 13.3 years, pooled r = 0.32, 95% CI 0.21-0.44), as well as between diastolic ambulatory BP and urine albumin excretion (five studies, n = 355, age 13.1 years, type 1 diabetes 42%, reflux nephropathy 28%, pooled r = 0.32, 95% CI 0.05-0.58). Two studies reported on the association between home BP and LVMI, with one of them showing comparable coefficients as for ambulatory monitoring. The available evidence suggests a moderate but significant association between ambulatory BP and preclinical organ damage, mainly based on studies in nephropathy and/or diabetes. More data are needed in essential hypertension without nephropathy or diabetes, as well as with home measurements.

20 February 2014 in Hypertension Research
Verified
Journal Article
Open access
PDF file
GSGeorge Stergiou
George Stergiou
ANAngeliki Ntineri
Angeliki Ntineri
Anastasios KolliasAnastasios Kollias
Anastasios Kollias
TOTakayoshi Ohkubo
Takayoshi Ohkubo
YIYutaka Imai
Yutaka Imai
GPGianfranco Parati
Gianfranco Parati
Accumulating evidence suggests that day-by-day blood pressure (BP) variability assessed using self-measurements by patients at home (HBPV) provides useful information beyond that of average home BP. This systematic review summarizes the current evidence on day-by-day HBPV. A systematic literature search (PubMed) revealed 22 eligible articles. Independent prognostic value of day-by-day HBPV for cardiovascular events and total mortality was demonstrated in two outcome studies, whereas novel indices of variability had minimal or no independent prognostic ability. Although findings are not consistent among the studies, the evidence suggests that HBPV has an independent role in the progression of preclinical cardiac, arterial and renal damage and is affected by age, gender, average BP and heart rate level, antihypertensive treatment, antihypertensive drug class and other factors. However, there is large diversity among the available studies in the home BP monitoring protocols, the indices used to quantify HBPV and the end points selected for evaluation. Overall, these preliminary data largely based on heterogeneous studies indicate an important and independent role of day-by-day HBPV in the pathogenesis of hypertension-induced cardiovascular damage. Yet, fundamental questions remain unanswered, including the optimal variability index, the optimal home monitoring schedule required, the threshold that defines increased HBPV and the impact of treatment-induced variability change on organ damage and cardiovascular events. Until these questions are adequately addressed in future studies, HBPV should largely remain a research issue with limited practical value for individual patients.

1 March 2017 in Journal Of Hypertension
Verified
Journal Article
Closed access
PDF file
Anastasios KolliasAnastasios Kollias
Anastasios Kollias
ANAngeliki Ntineri
Angeliki Ntineri
GSGeorge Stergiou
George Stergiou
Night-time ambulatory blood pressure (nABP) is the most important aspect of the blood pressure profile in terms of prognosis. Novel low-cost home monitors allow automated night-time blood pressure monitoring (nHBP). This study reviewed the evidence on the association of nHBP with nABP and preclinical organ damage. Systematic review and meta-analysis. Analysis of six studies (n = 1404) showed pooled difference between nHBP and nABP (SBP/DBP) at 1.4, 95% confidence interval (CI) 0.3, 2.6/−0.2, 95% CI −0.9, 0.6 mmHg, whereas the pooled correlation coefficient between nHBP and nABP (SBP/DBP) was r = 0.70, 95% CI 0.59, 0.81/r = 0.72, 95% CI 0.67, 0.77, respectively. Two studies (n = 212) investigated the agreement between nHBP and nABP in detecting nondippers with weighted agreement 77.3% (pooled kappa 0.27, 95% CI 0.08, 0.45). Three studies (n = 954) reported on the association of left ventricular mass index with systolic nHBP and nABP (pooled correlation coefficient r = 0.36, 95% CI 0.23, 0.50 and r = 0.32, 95% CI 0.10, 0.54, respectively, P = NS for comparison). Two studies (n = 950) reported on the association of urinary albumin excretion with systolic nHBP and nABP (pooled r = 0.39, 95% CI 0.21, 0.58 and r = 0.30, 95% CI 0.06, 0.55, respectively, P < 0.01 for comparison). Two studies (n = 350) reported on the association of common carotid intima–media thickness with systolic nHBP and nABP (pooled r = 0.31, 95% CI 0.16, 0.46 and r = 0.35, 95% CI 0.17, 0.53, respectively, P = NS for comparison). The available evidence suggests that nHBP and nABP present similar values and comparable relationship with target-organ damage. Studies on the prognostic value of nHBP are needed.

13 June 2014 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
GSGeorge Stergiou
George Stergiou
Anastasios KolliasAnastasios Kollias
Anastasios Kollias
MZMarilena Zeniodi
Marilena Zeniodi
NKNikos Karpettas
Nikos Karpettas
ANAngeliki Ntineri
Angeliki Ntineri

1 July 2015 in Journal of the American Society of Hypertension
Verified
Journal Article
Closed access
GSGeorge Stergiou
George Stergiou
ANAngeliki Ntineri
Angeliki Ntineri
Anastasios KolliasAnastasios Kollias
Anastasios Kollias
ADAntonios Destounis
Antonios Destounis
ENEfthimia Nasothimiou
Efthimia Nasothimiou
LRLeonidas Roussias
Leonidas Roussias

1 April 2018 in Blood Pressure Monitoring
Verified
Journal Article
Closed access
PDF file
Anastasios KolliasAnastasios Kollias
Anastasios Kollias
ANAngeliki Ntineri
Angeliki Ntineri
KKKonstantinos G. Kyriakoulis
Konstantinos G. Kyriakoulis
ESEmelina Stambolliu
Emelina Stambolliu
SLStyliani Lagou
Styliani Lagou
GSGeorge Stergiou
George Stergiou
To assess the accuracy of the professional oscillometric blood pressure (BP) monitor Microlife WatchBP Office in adults and children according to the American National Standards Institute/Association for the Advancement of Medical Instrumentation/International Organization for Standardization (ANSI/AAMI/ISO) 81060-2:2013 standard. Adults and children (aged 3–12 years) were recruited to fulfil the age, sex, BP and cuff distribution criteria of the ANSI/AAMI/ISO standard using the same-arm sequential BP measurement method. Three cuffs of the test device were used for arm circumferences of 14–22, 22–32 and 32–42 cm. A total of 115 participants were recruited and 88 were included in the analysis (51 adults and 37 children). For criterion 1, the mean±SD of the differences between the test device and reference BP was −1.0±7.0/−4.7±5.4 mmHg (systolic/diastolic). For criterion 2, the SD of the averaged BP differences between the test device and reference per participant was 5.15/4.77 mmHg (systolic/diastolic). The professional Microlife WatchBP Office BP monitor fulfilled the requirements of the ANSI/AAMI/ISO validation standard for adults and children and can be recommended for clinical use.